Biote Announces Terry Weber Retiring As CEO And Director And Transitioning To Strategic Advisor To Company's Board Of Directors; Bret Christensen To Succeed As CEO And Director, Effective February 1, 2025.

Terry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company's Board of Directors

Health Care Veteran Bret Christensen to Succeed Terry Weber as CEO and Director

biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Terry Weber is retiring as Chief Executive Officer and stepping down from the Company's Board of Directors, effective as of February 1, 2025. She will be transitioning to Strategic Advisor to the Company's Board of Directors. Concurrently, Mr. Bret Christensen has been named Chief Executive Officer and Director, effective February 1, 2025.